BioMarin Pharmaceutical Inc. Common Stock (NASDAQ: BMRN) last traded at $55.14, up 1.40% on the session. The quote above updates while this page is open; the figures below are drawn from BioMarin Pharmaceutical Inc. Common Stock’s own filings and are restated only when a new one is published.
BioMarin Pharmaceutical Inc. Common Stock trades on NASDAQ under the ticker BMRN. Its market capitalisation is $10.67 billion.
Valuation measures for BioMarin Pharmaceutical Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $10.67B |
|---|---|
| Enterprise value | $15.20B |
| P/E ratio | 141.38 |
| Price / sales | 3.13 |
| Price / book | 1.69 |
| Beta |
| 0.35 |
Trailing-twelve-month figures tagged in BioMarin Pharmaceutical Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $3.41B |
|---|---|
| Net income (TTM) | $72.97M |
| EPS (TTM) | $0.390 |
| Gross margin | 76.12% |
| Operating margin | 4.38% |
| Return on equity | 1.15% |
| Cash | $874.00M |
Range and volume for BMRN over the past 52 weeks.
| 52-week high | $70.98 |
|---|---|
| 52-week low | $49.26 |
| Volume | 1.85M |
| Average volume | 2.08M |
| Previous close | $54.38 |
Invest a chosen dollar amount in BioMarin Pharmaceutical Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BMRN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.